Preview Mode Links will not work in preview mode

Mar 15, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 2: Triple-Negative Breast Cancer — Priyanka Sharma, MD


CME information and select...


Mar 15, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 1: HER2-Positive Breast Cancer — Ian E Krop, MD, PhD


CME information and select...


Mar 15, 2024

Featuring perspectives from Dr Ian E Krop and Dr Priyanka Sharma, including the following topics: 
  • Introduction: Educating Non-Breast Cancer Specialty Oncologists About HER2-Targeted Therapies – ASCO Genitourinary Cancers Symposium 2024 (0:00)
  • HER2-Positive Breast Cancer — Dr Krop (12:30)
  • Triple-Negative Breast...


Mar 11, 2024

Featuring a slide presentation and related discussion from Dr Komal Jhaveri, including the following topics:

  • Role of ESR1 mutations in sensitivity and resistance to endocrine therapy in patients with ER-positive metastatic breast cancer (0:00)
  • Efficacy and safety of oral SERDs in patients with ER-positive metastatic...


Mar 11, 2024

Featuring an interview with Dr Komal Jhaveri, including the following topics:

  • Case: A woman in her mid 50s with ER-positive, HER2-low (IHC 1+) metastatic breast cancer with an ESR1 mutation (0:00)
  • Case: A woman in her late 40s with ER-positive, HER2-low ESR1 wild-type metastatic breast cancer who received imlunestrant...